Hacker News Reader

>can run a complete blood-cell count

I'm not a biologist but getting a "count" seems way easier and more realistic than Theranos' claims of reliably detecting diabetes, heart disease, cancer from a single prick of blood. Therefore, I'm not surprised that Sequoia backed them even though Theranos may have poisoned the well for other bio-tech startups.

View on HN

And perhaps already accomplished? (with FDA approval)

https://www.medonic.se/products/

Don't know if they're going beyond the capabilities there, I'd have to assume they are.

"Not available for sales in the USA"

And these are point-of-care devices, not DTC devices. There are a lot of POC diagnostics devices out there and very few DTC diagnostic devices.

Huh. Well, my company performs cancer diagnostics using blood samples and we use a Medonic to get a WBC count prior to processing and image analysis.

automated diff counters are relatively new compared to chemistry analyzers (diabetes, heart disease). Cancer is a whole 'nother league.

Reply on news.ycombinator.com